Karel Odrážka

1.8k total citations
58 papers, 452 citations indexed

About

Karel Odrážka is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Karel Odrážka has authored 58 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 23 papers in Radiation and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Karel Odrážka's work include Advanced Radiotherapy Techniques (23 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Prostate Cancer Treatment and Research (14 papers). Karel Odrážka is often cited by papers focused on Advanced Radiotherapy Techniques (23 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Prostate Cancer Treatment and Research (14 papers). Karel Odrážka collaborates with scholars based in Czechia and United Kingdom. Karel Odrážka's co-authors include Martin Doležel, J Vaňásek, Jiřı́ Petera, Petr Paluska, Milan Vošmik, Miloš Broďák, J Vizdá, Jan Jansa, Stanislav Filip and Bohuslav Melichar and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Gynecologic Oncology and Radiation Research.

In The Last Decade

Karel Odrážka

55 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karel Odrážka Czechia 13 244 157 124 107 92 58 452
Martin Doležel Czechia 12 198 0.8× 147 0.9× 109 0.9× 86 0.8× 92 1.0× 55 423
Tsuyoshi Takanaka Japan 14 242 1.0× 83 0.5× 221 1.8× 116 1.1× 94 1.0× 34 542
Vanessa Di Cataldo Italy 14 296 1.2× 170 1.1× 119 1.0× 124 1.2× 170 1.8× 61 579
Madoka Morota Japan 12 183 0.8× 79 0.5× 192 1.5× 56 0.5× 104 1.1× 23 429
Haruo Inokuchi Japan 14 240 1.0× 123 0.8× 125 1.0× 68 0.6× 149 1.6× 39 483
Sei‐Chul Yoon South Korea 15 200 0.8× 109 0.7× 223 1.8× 124 1.2× 204 2.2× 25 619
Berna Akkuş Yıldırım Türkiye 13 183 0.8× 66 0.4× 109 0.9× 94 0.9× 177 1.9× 64 484
Roman O. Kowalchuk United States 11 144 0.6× 52 0.3× 98 0.8× 91 0.9× 84 0.9× 50 367
Benedetta Agresti Italy 12 166 0.7× 144 0.9× 130 1.0× 108 1.0× 137 1.5× 36 467
H Niibe Japan 11 165 0.7× 48 0.3× 183 1.5× 87 0.8× 107 1.2× 47 441

Countries citing papers authored by Karel Odrážka

Since Specialization
Citations

This map shows the geographic impact of Karel Odrážka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karel Odrážka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karel Odrážka more than expected).

Fields of papers citing papers by Karel Odrážka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karel Odrážka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karel Odrážka. The network helps show where Karel Odrážka may publish in the future.

Co-authorship network of co-authors of Karel Odrážka

This figure shows the co-authorship network connecting the top 25 collaborators of Karel Odrážka. A scholar is included among the top collaborators of Karel Odrážka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karel Odrážka. Karel Odrážka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaňásek, J, Karel Odrážka, Bohuslav Melichar, et al.. (2019). Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer. Biomedical Papers. 163(4). 285–292. 6 indexed citations
2.
Vaňásek, J, Karel Odrážka, Ladislav Dušek, et al.. (2019). Is There a Benefit of HER2-Positive Breast Cancer Subtype Determination in Clinical Practice?. Klinicka onkologie. 32(1).
3.
Vaňásek, J, et al.. (2018). Tumor bed radiotherapy in women following breast conserving surgery for breast cancer-safety margin with/without image guidance. Oncology Letters. 15(4). 6009–6014. 8 indexed citations
4.
Vaňásek, J, Karel Odrážka, Ladislav Dušek, et al.. (2014). Experience with intensity-modulated radiotherapy in the treatment of head and neck cancer.. PubMed. 18(4). 970–6. 3 indexed citations
5.
6.
Odrážka, Karel, Martin Doležel, J Vaňásek, et al.. (2013). Five-Year Results of IMRT for Prostate Cancer – Tumor Control. Klinicka onkologie. 26(6). 415–420. 1 indexed citations
7.
8.
Vaňásek, J, Karel Odrážka, Ladislav Dušek, et al.. (2012). PET/CT significance for planning radiotherapy of head and neck cancer. Neoplasma. 59(5). 536–540. 5 indexed citations
9.
Odrážka, Karel, et al.. (2011). Magnetic Resonance Imaging in Postprostatectomy Radiotherapy Planning. International Journal of Radiation Oncology*Biology*Physics. 82(2). 911–918. 20 indexed citations
10.
Odrážka, Karel, Martin Doležel, J Vaňásek, et al.. (2010). Chronická urinární toxicita 3D-CRT a IMRT karcinomu prostaty. 14(3). 156–163. 2 indexed citations
11.
Odrážka, Karel, et al.. (2010). [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].. PubMed. 23(4). 256–63. 1 indexed citations
12.
Vošmik, Milan, Petr Paluska, Jiřı́ Petera, et al.. (2008). IMRT using simultaneous integrated boost (66 Gy in 6 weeks) with and without concurrent chemotherapy in head and neck cancer – toxicity evaluation. Reports of Practical Oncology & Radiotherapy. 13(2). 86–95. 4 indexed citations
13.
Vošmik, Milan, et al.. (2007). Solitary Extramedullary Plasmacytoma in the Oropharynx: Advantages of Intensity-Modulated Radiation Therapy. Clinical Lymphoma & Myeloma. 7(6). 434–437. 2 indexed citations
14.
15.
Odrážka, Karel, et al.. (2005). Comparison of rectal dose-volume constraints for IMRT prostate treatment planning. Physica Medica. 21(4). 129–135. 6 indexed citations
16.
Filip, Stanislav, et al.. (2004). Weekly Paclitaxel Combined with Local Hyperthermia in the Therapy of Breast Cancer Locally Recurrent after Mastectomy – a Pilot Experience. Oncology Research and Treatment. 27(4). 385–388. 22 indexed citations
17.
Petera, Jiřı́, et al.. (2004). High-Dose-Rate Interstitial Brachytherapy for the Treatment of Penile Carcinoma. Strahlentherapie und Onkologie. 180(2). 123–125. 8 indexed citations
18.
Ďulíček, Petr, et al.. (2003). [Asynchronous occurrence of three neoplastic diseases: chronic B-cell lymphatic leukemia, renal carcinoma and prostatic adenocarcinoma].. PubMed. 82(11). 583–6. 5 indexed citations
19.
20.
Filip, Stanislav, M. Bláha, Karel Odrážka, Pavel Měřička, & J Vávrová. (2000). Application of Whole Blood and Peripheral Blood Progenitor Cells (PBPC) and New Strategies for Rescue After Intensive Cyclic Chemotherapy in High-Risk Breast Cancer. Journal of Hematotherapy & Stem Cell Research. 9(1). 31–38. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Doležel Breakdown of academic impact, for papers by Tsuyoshi Takanaka Breakdown of academic impact, for papers by Vanessa Di Cataldo Breakdown of academic impact, for papers by Madoka Morota Breakdown of academic impact, for papers by Haruo Inokuchi Breakdown of academic impact, for papers by Sei‐Chul Yoon Breakdown of academic impact, for papers by Berna Akkuş Yıldırım Breakdown of academic impact, for papers by Roman O. Kowalchuk Breakdown of academic impact, for papers by Benedetta Agresti Breakdown of academic impact, for papers by H Niibe
Rankless by CCL
2026